FDA Halts One of the First Human CRISPR Studies Before it Begins (technologyreview.com)
A trial planning to use the gene-editing tool CRISPR on sickle cell patients has been put on hold due to unspecified questions from US regulators. From a report: CRISPR Therapeutics, which is developing the therapy, sought approval from the US Food and Drug Administration in April to begin the study. The therapy involves extracting stem cells from a patient's bone marrow and editing them with CRISPR in the lab. Once infused back into the patient, the idea is that the edited cells would give rise to healthy red blood cells. But according to a statement on Wednesday from CRISPR Therapeutics, the FDA ordered the company not to proceed with its study until it answers questions about its CRISPR treatment.
FDA once in a while does its job, amazing
Comment removed based on user account deletion
If I want to turn myself into some kind of vampire bat-man that feeds on human blood to sustain my nocturnal life, I have every right to do it, and then to turn to a life of vigilantism for the fun of beating people up and stealing their vital fluids.
No government will stop me, because I am vengeance, I am the night, I am the MAN-BAT!
I'm generally not big on layers of bureaucratic red tape, but for an emergent technology like this it seems absolutely appropriate to take an extra cautious approach for the moment.
I'd hate to conduct animal testing on this procedure.
I'm sure these guys could come up with a name that doesn't make people instantly think of the electric chair.
whats ur deal wierdo
I think they should allow Human trials on terminal patients
0862 a777 9d57 eaee
c14f 05af bc1c 51f9
10af 49d7 b968 cd81
e7b6 6335 6715 d72f
c748 6bd3 ca16 c496
6d86 f539 dfa5 0380
aa42 4614 d44c 1704
aa0f 60c1 a4c5 0589
One problem with these gene-editing treatments is that it is very hard to measure the safety of the treatment. It could be that the company tried to show how it would measure safety, but FDA wasn't satisfied with the process.
Chemical and Engineering News (probably behind a paywall) has an article about how companies are trying to come to a consensus on how to measure safety. https://cen.acs.org/pharmaceut...
A huge problem here is that DNA breaks all the time in our cells and gets repaired. That is the exact process CRISPR leverages to make its edits. So, how do you tell a natural break and mis-repair from a misdirected CRISPR edit. Not an easy thing to tell. FDA wants the applicant to show safety, not for someone else to show dangerousness. Proving a thing that is very difficult to measure in the first place is a great challenge, and may keep these treatments from advancing at FDA.
The Europeans have a similar issues with their beta-thalassemia trial. https://www.bionews.org.uk/pag...
You misspelled you're
Comment removed based on user account deletion
FDA once in a while does its job, amazing
That depends entirely on the line of questioning. If it is something along the lines of "we have reason to suspect this may pose a risk to patients due to scientific evidence A, B, and C (citations provided)" then yeah, it's a good thing.
If it is something along the lines of "Aren't you violating God's mandate by editing His(tm) perfect genome and the fate He(tm) has decreed for these patients," which is not something I'd put past this administration (and how interesting that the question(s) are secret), then no, this is anything but a good thing.
Either way, we can expect China et al to step into the breach and progress the technology, leaving the US in their dust like they did with Stem Cell research under W.
If you're not at all amusing in person - and we both know you're not - what the fuck makes you think any of that would be funny in print??
I don't understand in today's world of multi billion dollar corps why they don't buy a decommissioned cruse ship and park it 25 miles off the coast of CA and do whatever the hell they want on the boat. Want to risk the CRISPR treatment, take a boat ride out to international waters and make it happen.
FDA once in a while does its job, amazing
That depends entirely on the line of questioning. If it is something along the lines of "we have reason to suspect this may pose a risk to patients due to[...]
The FDA is a bureaucracy responsible for the safety of patients, but bears none of the costs of that safety.
It is in the FDA's interest to make the safety bar so high that medical progress is stifled, so long as safety is its primary goal. Medical companies are always at odds with the FDA, trying to negotiate more sane procedures and reliances.
Taking this article as an example, the patients are completely cut out of the equation. The patients might have a terminal disease with a projected survival of a few years, or might have an awful quality of life - and yet, they cannot choose to try this treatment. They cannot bear the risks from their own choices. The FDA lets patients die rather than have the possibility of an unsafe treatment.
It's ridiculous.
(And for a suggested alternative, let the FDA regulate *products*, not tests. Let the companies do studies and experiments on people willing to take part, and only step in when the treatment becomes publicly available. Add in a bit of legal protections and a standard value of human life - $5 million, say - and medical treadments would advance very quickly.)
This is the reason it exists as an organization, to protect the public and our health. I haven't agreed with everything they've done, and I'm not a huge fan of over-regulation. But, stopping and asking for more details before proceeding on something as new and potentially dangerous to the entire species as CRISPR is the correct approach.
Wasn't this the same thing that someone claimed they were going to stop looking into because "the GMO activists" could send a LOT of nasty emails and put them off their work? If so, I guess it proves that the complaint was a load of bollocks from the off, then. It was they were going to be asked by the FDA about it, and didn't want to answer.
IF the FDA uses its usual deliberate speed, we'll have CRISPR treatments, oh, after I die from something that could have been treated with CRISPR.
If they have questions, ASK THEM. QUICKLY. Get answers, get out of the way.
The FDA is a massively expensive formality, an obstacle of saving lives with allegations of corruption all over the place.
If the FDA told me to eat undercooked meat would I do it. No way !
Did the FDA write The Jungle expose that uncovered the unsanitary practices of food handling? No, it was a private citizen, Upton Sinclair.
How many medical/pharmeceutical breakthroughs happen in over regulated Europe? None.
Does it do anything? Maybe, but better off without it.
I think people should be able to design their children. A five foot three inch man and a five foot even woman may want more for their child.
See, height matters in ALL aspects of human society. It's a subconscious reaction because deep down, we're monkeys and we respond to the alphas. And height makes one an alpha.
And intellect too. The US Army won't take anyone with an IQ lower than 85. Why? Because people with that low of an IQ cannot be trained for anything. That's 10% of the population.
A world like that great sci-fi movie Gattaca? Let's go!
I'm holding out for the CRSPN-GLOVR treatment. It is our density.
Comment removed based on user account deletion
Just move the fuck over the border to Mexico or another country. My medical treatment is a matter between me and my doctor. Yes, it could kill me, still my decision. FUCK OFF FDA.
You don't, eh? So much for the:
In Soviet Washington the swamp drains you.
So the article is just about some bureaucratic mumbojumbo like _always_ when such trials start.
I guess form 643a got stuck in the mail and now we get a crappy story here.
Tell us when they cured the guys but not every step to get the authorization to begin.
shades of "Cancer. The Forbidden Cure".
https://www.youtube.com/watch?...
The more interesting part is the following, from a CRISPR press release: The planned initiation of a Phase 1/2 trial of CTX001 in Europe in adult patients with transfusion dependent Beta-thalassemia is unchanged, and the companies expect to initiate the trial in the second half of 2018. Therefore, ex vivo CRISPR gene-edited therapies are actually about to go into trails. The SCD treatment has hit a very small bump in the road, which is expected and less of a story.
This company and their claims sounds exactly like Theranos. Anybody remember Theranos? The company that FAKED the capabilities of their product?
FDA is 100% right when halting the "experiment" until they answer questions and show proof that can be duplicated.
BTW, Why is the CEO of Theranos still walking on the streets? She committed fraud in the most heinous of ways and possibly caused many deaths due to the fake results the company provided.
The more coupling there is between corporations and the federal agencies that are supposed to regulate them, the less you need a tinfoil hat to wonder if influential companies might use the FDA to obstruct research that could result in products that threaten their business. We live in an age of medical maintenance, not cures. How long has it been since the last eradication of a major disease? I have to wonder if we'll ever see cures for diseases such as diabetes that support multi-billion dollar maintenance industries.
So what are the reasons?
What about "Right to try"?
Self-importance and self-indulgence is the root of ALL evil.